NEW DELHI : Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.BIRAC has facilitated the establishment of 'the r-VSV vaccine' manufacturing platform for the first time in India by supporting Aurobindo Pharma's COVID-19 vaccine development, the company said in a regulatory filing.Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines.
The vaccine candidate is based on a proprietary vaccine delivery platform of the company."Aurobindo is in the process of setting up a state-of-art manufacturing facility for viral vaccines which will.